A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease-Reference-Cited by-同舟云学术

A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease

Published:2010-09 Issue:3 Volume:4 Page:221-256
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:Journal of Crohn's and Colitis

Author:

Miehsler W.,Novacek G.,Wenzl H.,Vogelsang H.,Knoflach P.,Kaser A.,Dejaco C.,Petritsch W.,Kapitan M.,Maier H.,Graninger W.,Tilg H.,Reinisch W.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/4/3/221/1025018/4-3-221.pdf

Reference438 articles.

1. European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease;Rahier;JCC,2009

2. Incidence and clinical significance of immunogenicity to infliximab in Crohn's disease: a critical review;Cassinotti;Inflamm Bowel Dis,2009

3. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's diseaese;Baert;N Engl J Med,2003

4. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial;Hanauer;Lancet,2002

5. Immunogenicity of anti-tumor necrosis factor antibodies-toward improved methods of anti-antibody measurement;Aarden;Curr Opin Immunol,2008

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risks and benefits of anti-TNF therapy for ulcerative colitis in a patient with autoimmune hepatitis-related cirrhosis: Case report;Medicine;2024-08-02

2. Infliximab in steroid-refractory immune-related hepatitis does not demonstrate hepatotoxicity and may shorten time on steroids;Journal for ImmunoTherapy of Cancer;2024-07

3. Immune-Targeted Therapies for Depression;The Journal of Clinical Psychiatry;2024-06-24

4. Febrile neutropenia associated with adalimumab in a patient with ulcerative colitis;Clinical Case Reports;2024-03-27

5. THE EFFECT OF TNF-ALPHA INHIBITORS USED IN RHEUMATOLOGIC DISEASES ON HEMATOLOGICAL PARAMETERS;Rheumatology Quarterly;2024-03-01